Getinge AB (GNGBY)
24.24
0.00 (0.00%)
USD |
OTCM |
Sep 17, 16:00
Getinge Enterprise Value : 7.101B for Sept. 17, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 17, 2026 | 7.101B |
| September 16, 2026 | 7.101B |
| September 15, 2026 | 7.149B |
| September 14, 2026 | 7.149B |
| September 11, 2026 | 7.063B |
| September 10, 2026 | 7.117B |
| September 09, 2026 | 7.233B |
| September 08, 2026 | 7.271B |
| September 04, 2026 | 7.346B |
| September 03, 2026 | 7.434B |
| September 02, 2026 | 7.345B |
| September 01, 2026 | 7.345B |
| August 31, 2026 | 7.459B |
| August 28, 2026 | 7.459B |
| August 27, 2026 | 7.482B |
| August 26, 2026 | 7.482B |
| August 25, 2026 | 7.482B |
| August 24, 2026 | 7.482B |
| August 21, 2026 | 7.482B |
| August 20, 2026 | 7.497B |
| August 19, 2026 | 7.500B |
| August 18, 2026 | 7.337B |
| August 17, 2026 | 7.327B |
| August 14, 2026 | 7.333B |
| August 13, 2026 | 7.289B |
| Date | Value |
|---|---|
| August 12, 2026 | 7.289B |
| August 11, 2026 | 7.308B |
| August 10, 2026 | 7.337B |
| August 07, 2026 | 7.299B |
| August 06, 2026 | 7.284B |
| August 05, 2026 | 7.325B |
| August 04, 2026 | 7.335B |
| August 03, 2026 | 7.307B |
| July 31, 2026 | 7.261B |
| July 30, 2026 | 7.235B |
| July 29, 2026 | 7.195B |
| July 28, 2026 | 7.103B |
| July 27, 2026 | 6.942B |
| July 24, 2026 | 6.943B |
| July 23, 2026 | 6.891B |
| July 22, 2026 | 7.031B |
| July 21, 2026 | 7.017B |
| July 20, 2026 | 7.012B |
| July 17, 2026 | 7.086B |
| July 16, 2026 | 6.455B |
| July 15, 2026 | 6.412B |
| July 14, 2026 | 6.356B |
| July 13, 2026 | 6.412B |
| July 10, 2026 | 6.399B |
| July 09, 2026 | 6.285B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Xvivo Perfusion AB | 783.66M |
| Paxman AB | 71.82M |
| Enovis Corp. | 2.385B |
| Edwards Lifesciences Corp. | 47.44B |
| Intuitive Surgical, Inc. | 130.62B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 89.59M |
| Revenue (Quarterly) | 894.98M |
| Total Expenses (Quarterly) | 805.18M |
| EPS Diluted (Quarterly) | 0.3297 |
| Gross Profit Margin (Quarterly) | 49.35% |
| Profit Margin (Quarterly) | 10.01% |
| Earnings Yield | 4.32% |
| Operating Earnings Yield | 7.50% |
| Normalized Earnings Yield | 4.516 |